These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 22680981

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Chronic renal failure among HIV-1-infected patients.
    Mocroft A, Kirk O, Gatell J, Reiss P, Gargalianos P, Zilmer K, Beniowski M, Viard JP, Staszewski S, Lundgren JD.
    AIDS; 2007 May 31; 21(9):1119-27. PubMed ID: 17502722
    [Abstract] [Full Text] [Related]

  • 23. Renal function in patients with preexisting renal disease receiving tenofovir-containing highly active antiretroviral therapy in the HIV outpatient study.
    Young B, Buchacz K, Moorman A, Wood KC, Brooks JT, HIV Outpatient Study (HOPS) Investigators.
    AIDS Patient Care STDS; 2009 Aug 31; 23(8):589-92. PubMed ID: 19591609
    [Abstract] [Full Text] [Related]

  • 24. Acute interstitial nephritis of HIV-positive patients under atazanavir and tenofovir therapy in a retrospective analysis of kidney biopsies.
    Schmid S, Opravil M, Moddel M, Huber M, Pfammatter R, Keusch G, Ambuhl P, Wuthrich RP, Moch H, Varga Z.
    Virchows Arch; 2007 Jun 31; 450(6):665-70. PubMed ID: 17464512
    [Abstract] [Full Text] [Related]

  • 25. Effect of baseline renal function on tenofovir-containing antiretroviral therapy outcomes in Zambia.
    Mulenga L, Musonda P, Mwango A, Vinikoor MJ, Davies MA, Mweemba A, Calmy A, Stringer JS, Keiser O, Chi BH, Wandeler G, IeDEA-Southern Africa.
    Clin Infect Dis; 2014 May 31; 58(10):1473-80. PubMed ID: 24585558
    [Abstract] [Full Text] [Related]

  • 26. Increased time exposure to tenofovir is associated with a greater decrease in estimated glomerular filtration rate in HIV patients with kidney function of less than 60 ml/min/1.73 m2.
    Fafin C, Pugliese P, Durant J, Mondain V, Rahelinirina V, De Salvador F, Ceppi C, Perbost I, Rosenthal E, Roger PM, Cua E, Dellamonica P, Esnault V, Pradier C, Moranne O.
    Nephron Clin Pract; 2012 May 31; 120(4):c205-14. PubMed ID: 23037894
    [Abstract] [Full Text] [Related]

  • 27. Impact of small body weight on tenofovir-associated renal dysfunction in HIV-infected patients: a retrospective cohort study of Japanese patients.
    Nishijima T, Komatsu H, Gatanaga H, Aoki T, Watanabe K, Kinai E, Honda H, Tanuma J, Yazaki H, Tsukada K, Honda M, Teruya K, Kikuchi Y, Oka S.
    PLoS One; 2011 May 31; 6(7):e22661. PubMed ID: 21799928
    [Abstract] [Full Text] [Related]

  • 28. High rate of reversibility of renal damage in a cohort of HIV-infected patients receiving tenofovir-containing antiretroviral therapy.
    Bonjoch A, Echeverría P, Perez-Alvarez N, Puig J, Estany C, Clotet B, Negredo E.
    Antiviral Res; 2012 Oct 31; 96(1):65-9. PubMed ID: 22892171
    [Abstract] [Full Text] [Related]

  • 29. Evolution of glomerular filtration rate in HIV-infected, HIV-HBV-coinfected and HBV-infected patients receiving tenofovir disoproxil fumarate.
    Pradat P, Le Pogam MA, Okon JB, Trolliet P, Miailhes P, Brochier C, Maynard M, Bailly F, Zoulim F, Cotte L.
    J Viral Hepat; 2013 Sep 31; 20(9):650-7. PubMed ID: 23910650
    [Abstract] [Full Text] [Related]

  • 30. Risk of cerebrovascular events in persons with and without HIV: a Danish nationwide population-based cohort study.
    Rasmussen LD, Engsig FN, Christensen H, Gerstoft J, Kronborg G, Pedersen C, Obel N.
    AIDS; 2011 Aug 24; 25(13):1637-46. PubMed ID: 21646903
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Chronic kidney disease and HIV in the era of antiretroviral treatment: findings from a 10-year cohort study in a west African setting.
    Kaboré NF, Poda A, Zoungrana J, Da O, Ciaffi L, Semdé A, Yaméogo I, Sawadogo AB, Delaporte E, Meda N, Limou S, Cournil A.
    BMC Nephrol; 2019 May 07; 20(1):155. PubMed ID: 31064340
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study.
    Mocroft A, Lundgren JD, Ross M, Fux CA, Reiss P, Moranne O, Morlat P, Monforte Ad, Kirk O, Ryom L, Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) Study.
    Lancet HIV; 2016 Jan 07; 3(1):e23-32. PubMed ID: 26762990
    [Abstract] [Full Text] [Related]

  • 35. Similar risk of renal events among patients treated with tenofovir or entecavir for chronic hepatitis B.
    Gish RG, Clark MD, Kane SD, Shaw RE, Mangahas MF, Baqai S.
    Clin Gastroenterol Hepatol; 2012 Aug 07; 10(8):941-6; quiz e68. PubMed ID: 22507876
    [Abstract] [Full Text] [Related]

  • 36. Risk of cataract surgery in HIV-infected individuals: a Danish Nationwide Population-based cohort study.
    Rasmussen LD, Kessel L, Molander LD, Pedersen C, Gerstoft J, Kronborg G, Obel N.
    Clin Infect Dis; 2011 Dec 07; 53(11):1156-63. PubMed ID: 21998282
    [Abstract] [Full Text] [Related]

  • 37. A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naive HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenz.
    Albini L, Cesana BM, Motta D, Focà E, Gotti D, Calabresi A, Izzo I, Bellagamba R, Fezza R, Narciso P, Sighinolfi L, Maggi P, Quiros-Roldan E, Manili L, Guaraldi G, Lapadula G, Torti C.
    J Acquir Immune Defic Syndr; 2012 Jan 01; 59(1):18-30. PubMed ID: 21992924
    [Abstract] [Full Text] [Related]

  • 38. Changes in renal function with long-term exposure to antiretroviral therapy in HIV-infected adults in Asia.
    Joshi K, Boettiger D, Kerr S, Nishijima T, Van Nguyen K, Ly PS, Lee MP, Kumarasamy N, Wong W, Kantipong P, Cuong DD, Kamarulzaman A, Choi JY, Zhang F, Chaiwarith R, Ng OT, Kiertiburanakul S, Sim BLH, Merati TP, Yunihastuti E, Ditangco R, Ross J, Pujari S.
    Pharmacoepidemiol Drug Saf; 2018 Nov 01; 27(11):1209-1216. PubMed ID: 30246898
    [Abstract] [Full Text] [Related]

  • 39. Advanced chronic kidney disease, end-stage renal disease and renal death among HIV-positive individuals in Europe.
    Ryom L, Kirk O, Lundgren JD, Reiss P, Pedersen C, De Wit S, Buzunova S, Gasiorowski J, Gatell JM, Mocroft A, EuroSIDA in EuroCoord.
    HIV Med; 2013 Sep 01; 14(8):503-8. PubMed ID: 23590641
    [Abstract] [Full Text] [Related]

  • 40. Effect of Tenofovir Disoproxil Fumarate on Incidence of Chronic Kidney Disease and Rate of Estimated Glomerular Filtration Rate Decrement in HIV-1-Infected Treatment-Naïve Asian Patients: Results from 12-Year Observational Cohort.
    Suzuki S, Nishijima T, Kawasaki Y, Kurosawa T, Mutoh Y, Kikuchi Y, Gatanaga H, Oka S.
    AIDS Patient Care STDS; 2017 Mar 01; 31(3):105-112. PubMed ID: 28282247
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.